Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  01:27 2022-11-28 pm EST
49.53 USD   -0.33%
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wedbush Maintains Forecast
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
All news about PACIRA BIOSCIENCES, INC.
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wed..
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/08Pacira BioSciences to Present at Two Healthcare Conferences in November
GL
11/07BMO Capital Adjusts Price Target on Pacira BioSciences to $60 From $66, Maintains Marke..
MT
11/04HC Wainwright Adjusts Price Target on Pacira BioSciences to $76 From $83, Maintains Buy..
MT
11/04RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating
MT
11/04Wedbush Lowers Pacira BioSciences' Price Target to $88 From $94, Keeps Outperform Ratin..
MT
11/03PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
11/03Pacira BioSciences Q3 Non-GAAP Net Income Declines, Revenue Rises -- Shares Fall
MT
11/03Transcript : Pacira BioSciences, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
11/03Pacira : Q3 Earnings Snapshot
AQ
11/03Pacira BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months..
CI
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
GL
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
AQ
11/03Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q3 Revenue $167.5M, vs. Street Est of $1..
MT
11/03Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q3 EPS $0.64, vs. Street Est of $0.76
MT
10/21Jefferies Assumes Pacira BioSciences at Buy with $66 Price Target
MT
10/20Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
GL
10/20Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
AQ
10/13Pacira BioScience Reports Q3 Preliminary Revenue of $167.5 Million
MT
10/13Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
GL
10/13Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
AQ
10/13Pacira BioSciences, Inc. Announces Preliminary Unaudited Sales Results for the Month an..
CI
10/06RBC Raises Price Target on Pacira BioSciences to $82 From $81, Maintains Outperform Rat..
MT
09/27Pacira BioSciences, Sevaredent Partner Over Expanded Access to Exparel for Patients Und..
MT
09/27Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expand..
GL
09/27Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expand..
AQ
09/27Sevaredent Sourcing Solutions and Pacira BioSciences, Inc. Collaborate to Provide Expan..
CI
09/21Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
09/21Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
09/21Pacira Biosciences Announces Positive Topline Data from Phase 3 Study of Exparel as A S..
CI
09/20Pacira BioSciences Receives Positive Opinion for Post-Surgical Pain Treatment in Childr..
MT
09/20Pacira Receives Positive CHMP Opinion for EXPAREL« for the Treatment of Postsurgical Pa..
GL
09/20Pacira BioSciences, Inc. Receives Positive CHMP Opinion for Exparel« for the Treatment ..
CI
09/13Pacira BioSciences Reports August Net Sales
MT
09/13Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 20..
GL
09/13Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 20..
GL
09/13Pacira BioSciences, Inc. Announces Preliminary Net Product Sales Results for August 202..
CI
09/07Pacira BioSciences' Late-Stage Study of Pain Drug Meets Primary, Secondary Endpoints
MT
09/07Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
09/07Pacira Biosciences, Inc. Announces Positive Topline Data from Phase 3 Study of EXPAREL ..
CI
08/10Pacira BioSciences Reports July Preliminary Product Sales of $50.2 Million; Exparel Sal..
MT
08/10Pacira Biosciences : Reports Preliminary Net Product Sales of $50.2 Million for July 2022 ..
PU
08/10Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
GL
08/09NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti..
GL
08/09NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti..
GL
08/04RBC Cuts Price Target on Pacira BioSciences to $81 From $83, Maintains Outperform Ratin..
MT
08/03PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
08/03Pacira BioSciences Q2 Non-GAAP EPS Drops, Revenue Rises
MT
08/03Transcript : Pacira BioSciences, Inc., Q2 2022 Earnings Call, Aug 03, 2022
CI
08/03Pacira Biosciences : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/03Pacira : Q2 Earnings Snapshot
AQ
08/03Pacira BioSciences Reports Second Quarter 2022 Financial Results
GL
08/03Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 Revenue $169.4M
MT
08/03Pacira BioSciences Reports Second Quarter 2022 Financial Results
AQ
08/03Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q2 EPS $0.51
MT
08/03Pacira BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months..
CI
08/02Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
GL
08/02Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
AQ
07/27Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
GL
07/27Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
GL
07/21Piper Sandler Adjusts Price Target on Pacira BioSciences to $80 From $84, Reiterates Ov..
MT
07/14Pacira Biosciences : Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million - F..
PU
07/14Pacira BioSciences Reports Higher Preliminary Q2 Revenue
MT
07/14Pacira Biosciences, Inc. Not to Provide Revenue Guidance for the Fiscal Year 2022
CI
07/14Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
GL
07/14Pacira BioSciences Reports Revenues Results for the Second Quarter of 2022
CI
07/07RBC Raises Price Target on Pacira BioSciences to $83 From $81, Maintains Outperform Rat..
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcar..
MT
06/16National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
GL
06/16National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
PR
06/15Needham Adjusts Price Target on Pacira BioSciences to $76 From $84, Reiterates Buy Rati..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on PACIRA BIOSCIENCES, INC.